"Progress in Parkinson’s: from early signs to personalised intervention" with Prof A Noyce

In this session, we explored the frontiers of Parkinson’s research, focusing on the critical questions shaping the future of care. We asked Professor Noyce how linking research profiles with national health records creates a more accurate "roadmap" for disease progression and whether we are now able to categorise Parkinson’s into specific sub-types for more personalised medicine.

Key questions explored in this session include:

• The "Early Window": How can we act upon biological markers years before motor symptoms appear, and what role do lifestyle interventions like exercise and diet play in slowing the condition?
• Biological Staging: How close are we to a "Gold Standard" blood or skin test, and should we stop viewing Parkinson’s as a "motor disease" and start treating it as a systemic biological process?
• Technology & Innovation: How can we use consumer wearables to screen for early markers, and what biological pathways—such as inflammation or mitochondrial health—hold the most promise for a breakthrough?
• Global Reach: How is the PC3 project ensuring that new treatments are effective for diverse patient populations?
• Professor Noyce’s expert insights and his thoughts on the scientific milestones from the first half of 2026 that offer the most optimism.